Skip to content
Peptigraph home
Shop Peptides50% off*

KLOW for Inflammation: What the Evidence Shows

What human and animal studies show about KLOW for inflammation, how strong that evidence is, and what is still unproven.

Medical review pendingFour-peptide blendUpdated
Strongest evidence
Human RCT
from an ingredient's studies
Human studies
1
with an outcome for inflammation, in our evidence file (PubMed search, 11 Oct 2026)
Animal studies
10
with an outcome for inflammation, in our evidence file (PubMed search, 11 Oct 2026)
Studies we summarised
13
with an outcome for inflammation

Evidence for inflammation

Each row is an outcome related to inflammation from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here. No study has tested KLOW itself; rows are for each ingredient.

KLOW for inflammation: outcomes in published studies
OutcomeResultStudy typeSource
TB-500: Scalp seborrheic dermatitisThe thymosin beta-4 gel was reported more effective than ketoconazole lotion for scalp seborrheic dermatitis (randomization not stated in abstract).Human controlled trialn = 71Microbial biotechnology 2021, PMID 34318587
GHK-Cu: Colitis severity and mucosal repairGHK-Cu reduced weight loss, disease activity and colonic inflammatory damage and promoted mucosal repair in DSS colitis mice.Animal · mouse (plus mouse cell co-culture) (not a human result)Frontiers in pharmacology 2025, PMID 40672369
TB-500: Corneal alkali burnThe peptide-containing hydrogel accelerated corneal epithelial regeneration and reduced inflammation in an alkali burn model; this is a formulation study.Animal · human corneal cells in vitro plus an animal alkali burn model (species not stated in abstract) (not a human result)ACS applied materials & interfaces 2025, PMID 41359360
GHK-Cu: Lung inflammation and fibrosisGHK-Cu reduced lung inflammation and fibrosis in silicosis mice without significant systemic toxicity.Animal · mouse (plus macrophage cell line) (not a human result)Redox biology 2024, PMID 38879894
GHK-Cu: Lung inflammationGHK-Cu reduced lung histological changes and inflammatory cell infiltration in mice with acute lung injury.Animal · mouse (plus macrophage cell line) (not a human result)Oncotarget 2016, PMID 27517151
BPC-157: Colitis and anastomosis healingControl rats did not heal; BPC 157 induced healing of both cysteamine colitis and colon-colon anastomosis.Animal · rat (not a human result)Journal of physiology and pharmacology 2013, PMID 24304574
BPC-157: Periodontal inflammationBPC 157 treatment significantly reduced plasma extravasation, histological inflammation and alveolar bone resorption in ligature periodontitis.Animal · rat (not a human result)Journal of physiology and pharmacology 2009, PMID 20388954
KPV: DSS colitis recoveryKPV-treated mice recovered earlier and regained more body weight in DSS colitis.Animal · mouse (not a human result)Inflammatory bowel diseases 2008, PMID 18092346
KPV: Survival in MC1R-nonfunctional miceKPV treatment rescued all treated MC1R-nonfunctional mice from death during DSS colitis.Animal · mouse (not a human result)Inflammatory bowel diseases 2008, PMID 18092346
KPV: Colitis incidence (oral KPV)Oral KPV in drinking water reduced the incidence of DSS- and TNBS-induced colitis in mice and lowered inflammatory cytokine expression.Animal · mouse (plus human intestinal epithelial and T cell lines) (not a human result)Gastroenterology 2008, PMID 18061177
KPV: Peritonitis (neutrophil accumulation)KPV reduced inflammatory cell accumulation in mouse peritonitis through a mechanism distinct from other melanocortin peptides.Animal · mouse (not a human result)The Journal of pharmacology and experimental therapeutics 2003, PMID 12750433
KPV: FeverThe tripeptide reduced fever in rabbits after central (0.5-2.0 mg) and peripheral (2-200 mg) administration.Animal · rabbit (not a human result)Peptides 1984, PMID 6333677
KPV: Keratinocyte viability and IL-1betaKPV at 50 ug/mL restored cell viability and reduced IL-1beta secretion in PM10-exposed keratinocytes.In vitro (not a human result)Tissue & cell 2025, PMID 40073467
KPV: Airway epithelial inflammatory signallingKPV dose-dependently inhibited NF-kB signalling, MMP-9 activity, and IL8 and eotaxin secretion in cultured airway cells.In vitro (not a human result)International journal of physiology, pathophysiology and pharmacology 2012, PMID 22837805

KLOW and inflammation are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 11 Oct 2026). Grades follow our .

How strong is it?

Strongest evidence:Human RCT evidence, 4 of 4TB-500: Microbial biotechnology 2021, PMID 34318587

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

What inflammation is

MedlinePlus explains that long-lasting inflammation can damage healthy tissue.[14]

Anti-inflammatory outcomes reported for each component

GHK-Cu lowered TNF-α and IL-6 in lipopolysaccharide-injured mouse lungs and in lab-grown macrophages.[5]

GHK-Cu reduced lung inflammation and fibrosis in mice with silicosis.[4]

BPC-157 reduced inflammation and bone loss around a ligature-injured molar in rats.[7]

KPV acted through the PepT1 transporter to reduce inflammatory signalling in human gut cells in the lab.[9]

A recombinant thymosin beta-4 gel, which is a different product from TB-500, beat ketoconazole lotion for scalp seborrheic dermatitis in a human study.[1]

No PubMed record matched all four components together on 2 Oct 2026, so the blend as a mix has not been tested on inflammation.

Calculated from search GHK-Cu terms AND BPC-157 terms AND (TB-500 OR thymosin beta-4 terms) AND KPV terms; date 2026-10-02; count 0; page topic inflammation; source our combinations data ghk-cu__klow. Formula: records matching all four components = count = 0

Other peptides people research for inflammation

BPC-157TirzepatideKPVSemaglutideGHK-CuTB-500GLOWWolverine
All peptides for inflammation, compared

Common questions

Does KLOW help with inflammation?

The strongest study we summarise for inflammation is human rct evidence, for an ingredient rather than the blend, across 13 studies with an outcome for inflammation. A trial result is not an approval; see the legal status.

Is KLOW approved for inflammation?

No. KLOW is not FDA approved for any use, including inflammation.

What is the best peptide for inflammation?

There is no single answer. Our inflammation overview compares each candidate by evidence grade and legal status rather than by popularity.

Is KLOW anti-inflammatory?

Anti-inflammatory results exist for the separate components in animals and cells, and no human study of the blend exists.[1]

More on KLOW

DosageDoses used in published studies, with the source for each.Blend calculatorSplit a blend vial into per-peptide amounts and units.Side effectsWhat labels and studies report, and what is unknown.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.Legal statusFDA, compounding and WADA status with dates.

Sources

  1. 1Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.Microbial biotechnology · 2021PMID 34318587Accessed 2 Oct 2026
  2. 2Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms.Frontiers in pharmacology · 2025PMID 40672369Accessed 2 Oct 2026
  3. 3Alkaline Phosphatase-Triggered Spatiotemporal Repair of Corneal Injury with TB500 Peptide Hydrogel.ACS applied materials & interfaces · 2025PMID 41359360Accessed 2 Oct 2026
  4. 4The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6.Redox biology · 2024PMID 38879894Accessed 2 Oct 2026
  5. 5The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice.Oncotarget · 2016PMID 27517151Accessed 2 Oct 2026
  6. 6Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2013PMID 24304574Accessed 2 Oct 2026
  7. 7Antiinflammatory effect of BPC 157 on experimental periodontitis in rats.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2009PMID 20388954Accessed 2 Oct 2026
  8. 8Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.Inflammatory bowel diseases · 2008PMID 18092346Accessed 2 Oct 2026
  9. 9PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.Gastroenterology · 2008PMID 18061177Accessed 2 Oct 2026
  10. 10Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.The Journal of pharmacology and experimental therapeutics · 2003PMID 12750433Accessed 2 Oct 2026
  11. 11Effect of alpha-MSH 11-13 (lysine-proline-valine) on fever in the rabbit.Peptides · 1984PMID 6333677Accessed 2 Oct 2026
  12. 12Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.Tissue & cell · 2025PMID 40073467Accessed 2 Oct 2026
  13. 13Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists.International journal of physiology, pathophysiology and pharmacology · 2012PMID 22837805Accessed 2 Oct 2026
  14. 14Official web pageOfficial web page · web page

Found an error? Report a correction.